iCell® Cardiomyocytes - xCELLigence RTCA Cardio System Application Protocol

The xCELLigence RTCA Cardio System is a non-invasive, label-free platform that utilizes impedance changes across the cardiac monolayer to indirectly measure cardiomyocyte viability, contractility, and electrical activity. This Application Protocol describes how to handle iCell Cardiomyocytes for use on the xCELLigence RTCA Cardio System and provides basic instructions for compound treatments, data acquisition, and analysis.